
Site Map
Pages
- Annual Report
- News
- News Releases
- Our Customers
- PPD Inc
- Who We Are
- Company Resources
- Ethics
- Events
- Vendor Resources
- Legal Notices
- Cookie Policy
- Evidera UK England Wales Legal Information
- PPD UK England Wales Legal Information
- Privacy Notice for California Residents
- French Sunshine Act
- Modern Slavery Transparency Statement
- PPD Czech Republic, s.r.o.
- PPD Italy Srl Legal Information
- PPD UK Tax Strategy
- Healthcare Transparency
- PPD’s French Gender Pay Gap Reports
- PPD Global Limited Retirement Benefits Engagement Policy Implementation Statement
- PPD Global Limited Retirement Benefits Scheme Statement of Investment Principles
- PPD’s UK Gender Pay Gap Reports
- PPD in the News
- Privacy Policy
- Our Mission
- OUR 4i VALUES
- Corporate Responsibility
- Locations
- Company Resources
- How We Help
- Building Patient-Driven Trials
- Clinical Trial Certainty/Reliability
- Decentralized Clinical Trials
- 2020 Clinical Trial Insights Report
- 2021-2022 Decentralized Clinical Trials Industry Report
- Capabilities and Solutions
- Choosing DCTs
- Contact Digital Trials
- DCT Therapeutic Expertise
- DCT Trial Options Changing Respiratory Research
- Decentralized Clinical Trial Resources
- Decentralized Clinical Trials bring research to the patient
- Decentralized Clinical Trials Survey Report
- Mobile Clinical Research Sites
- Modern Strategies for Dermatology Clinical Trials
- Optimizing Research with Decentralized Strategies
- The Transformation of Clinical Trial Design and Operations
- Trials and Tribulations: How Decentralization is Evolving
- Why PPD DCT
- Expertise Asia Pacific
- Leveraging Identified Data
- Proven Delivery of COVID-19 Solutions
- Supporting Product Approval
- PPD Biotech
- Ensuring Business Continuity with PPD FSP
- Moving Medicine Forward Through Pivotal Moments
- Our Solutions
- Clinical Development
- Early Development
- Government and Public Health
- Medical Device Development
- Peri and Post-Approval
- Phase II-IV Clinical Trial Management
- Biostatistics
- Clinical Trial Monitoring
- Clinical Data Management
- Global Clinical Supplies
- Interactive Response Technology (IRT)
- Medical Writing
- Pharmacokinetic and Pharmacodynamic
- Pharmacovigilance
- Project Management
- Quality and Enterprise Learning
- Regulatory Affairs
- Functional Service Provider For Clinical Research
- Site and Patient Centric Solutions
- Product Development and Consulting
- Technology
- PPD Laboratory Services
- PPD® Laboratories: Part of the COVID-19 Solution
- Bioanalytical Lab
- Bioanalytical Biomarker Lab Overview
- Bioanalytical Laboratory Resources
- AAV Assay Development and AAV Cell-Based Neutralizing Assay Development
- Bioanalysis of Oligonucleotides: Ligand Binding and Chromatography
- Bioanalytical assays for gene therapy programs podcast
- Bioanalytical Strategies for Oligos
- Enzymatic Assays
- Flow Cytometry in Cell and Gene Therapy
- Molecular Genomics: Selecting qPCR and ddPCR
- Pre-Existing Antibodies: Considerations for Cell and Gene Therapy Products
- Bioanalytical Labs Validated Assay List
- BioA Capabilities
- BioA Experience and Expertise
- Contact Bioanalytical Lab
- PPD Laboratories Infographics
- Biomarker Lab
- Central Lab
- Central Laboratory Resources
- Continuous Development and Flexible Architecture of the Preclarus® Portal
- Innovative Solutions to Enhance Chain of Custody White Paper
- PBMC Processing Services
- PPD Laboratories’ Preclarus Lab Solutions White Paper
- Preclarus Lab Solutions White Paper
- Central Lab Capabilities
- Certifications
- Contact Central Lab
- Preclarus
- Thought Leadership Webinar Series
- GMP Lab
- Athlone Lab
- GMP Lab LC MS Services Article
- GMP Lab LC MS Services Overview
- GMP Lab LC MS Services Presentation
- GMP Laboratory Resources
- Cell and Gene Therapy Prerequisites
- Data Automation for Cell and Gene Therapy
- Extractable and Leachable Testing Methods: Including Special Case Compounds
- Extractables and Leacheables Compounds – Commonly Used and Detected from Polymer Materials
- How to Design an Extractables &and Leachables Program Suitable for Your Drug Product
- New Analytical Tools for Cell and Gene Therapy
- Overview: Extractables and Leachables Testing
- Regulatory Considerations for Cell and Gene Therapies
- Transfer of Bioanalytical Methods to GMP Lab
- GMP Capabilities
- GMP Experience and Expertise
- Contact GMP/CMC Lab
- Vaccine Sciences Lab
- PPD Laboratories FSP
- Clinical Development
- Therapeutic Areas
- Biosimilar Development
- Cell and Gene Therapy Capabilities
- Womens Health
- Cardiovascular
- Critical Care
- Dermatology
- Gastroenterology
- Immunology and Rheumatology
- Infectious Diseases
- Metabolic and Endocrine
- Neuroscience Research
- Oncology and Hematology
- Ophthalmology
- Pediatrics
- Rare Disease Clinical Trial Therapeutic Research
- Respiratory
- Urology
- Vaccine Development
- Nephrology and Renal Diseases
- Participate in a Trial
- Blog
- Contact Us
- Contact PPD® Digital And Decentralized Solutions
- Contact vaccine clinical development services
- Contact Early Development Services
- Contact Clinical Development Services
- Contact Peri- and Post-approval Services
- Contact Quality and Enterprise Learning Services
- Contact PPD® Laboratory Services
- Contact PPD Investigator Services
- Contact PPD Media Relations
- Contact PPD Webmaster
- Contact Our Consulting Services
- Contact Respiratory Services
- Contact Pharmacovigilance